Structural scheduling of synthetic cannabinoids

To combat the illicit synthetic cannabinoid industry many jurisdictions have created a system to control these cannabinoids through their general (or Markush) structure as opposed to their specific identity. In this way new analogs are already controlled before they are even created.[1][2] A large number of cannabinoids have been grouped into classes based on similarities in their chemical structure, and these classes have been widely adopted across a variety of jurisdictions.[3][4][5][6][7][8]

Typical groups of compounds included for control may include naphthoylindoles, phenylacetylindoles, benzoylindoles, cyclohexylphenols, naphthylmethylindoles, naphthoylpyrroles, naphthylmethylindenes, indole-3-carboxamides, indole-3-carboxylates, indazole-3-carboxamides and sometimes others, each with specific substitutions on specific atoms of the molecule.[9] The scope of definitions and the range of compounds included may vary substantially between jurisdictions, so compounds which are legal in one country or state may be illegal in another.[10]

For example, in many jurisdictions there is a general control on Naphthoylindoles: "Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent." (example definition from Kentucky, which is substantially derived from the 2009 ACMD advice on synthetic cannabinoids in the UK)[11][12] This causes a substance such as MAM-2201 to be controlled as a Schedule 1 illegal drug, even though "MAM-2201" or its corresponding chemical name are not specifically listed in the statute.

MAM-2201
MAM-2201

In the five carbon chain, the fluorine atom is attached to the nitrogen atom. A fluoropentyl chain falls within the scope of "haloalkyl" substitutions, and so with a methyl group attached to the carbon atom at the 4-position of the naphthyl ring (i.e. "substituted in the naphthyl ring to any extent"), and a fluoropentyl group attached to the nitrogen atom ("with substitution at the nitrogen atom of the indole ring by [a]...haloalkyl...group"), this compound falls within the scope of the general definition. It is in this way MAM-2201 can be controlled without being specifically named in the statute. On the other hand, THJ-2201 with an indazole core, falls outside this general definition, as it is a naphthoylindazole rather than a naphthoylindole. Note however that THJ-2201 is now specifically listed under US federal law.

  1. ^ Richardson, Kerri (May 31, 2012). "Governor Steve Beshear's Communications Office" – via Kentucky.gov.
  2. ^ Madigan, Lisa (2010). "Synthetic Drugs". Illinois Attorney General.
  3. ^ Harold, Holfner (13 February 2019). "Opti Health Patch: Does This CBD Patch Relieve Pain As Intended?". Mixel.cc. Retrieved 15 March 2019.
  4. ^ Wiley, JL; Marusich, JA; Huffman, JW (Feb 2014). "Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids". Life Sci. 97 (1): 55–63. doi:10.1016/j.lfs.2013.09.011. PMC 3944940. PMID 24071522.
  5. ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" (PDF) (in Japanese). 厚生労働省. 16 September 2015. Retrieved 8 October 2015.
  6. ^ Debruyne, D; Le Boisselier, R (2015). "Emerging drugs of abuse: current perspectives on synthetic cannabinoids". Subst Abuse Rehabil. 6: 113–29. doi:10.2147/SAR.S73586. PMC 4622447. PMID 26543389.
  7. ^ Shevyrin, V; Melkozerov, V; Endres, GW; Shafran, Y; Morzherin, Y (2016). "On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances". Cannabis and Cannabinoid Research. 1: 186–194. doi:10.1089/can.2016.0004. hdl:10995/75105.
  8. ^ Akutsu, M; Sugie, K; Saito, K (2017). "Analysis of 62 synthetic cannabinoids by gas chromatography–mass spectrometry with photoionization". Forensic Toxicol. 35 (1): 94–103. doi:10.1007/s11419-016-0342-9. PMC 5214763. PMID 28127409.
  9. ^ Abbate V, et al. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure and Applied Chemistry 2018; 90(8):1256-1279. doi:10.1515/pac-2017-0605
  10. ^ "Legal approaches to controlling new psychoactive substances. EMCDDA, 2016" (PDF).
  11. ^ "KRS 218A.010 (45) (a)".
  12. ^ "Consideration of the major cannabinoid agonists. ACMD, 2009" (PDF).

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search